CDR2 antibody (C-Term)
Quick Overview for CDR2 antibody (C-Term) (ABIN600997)
Target
See all CDR2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Recognizes human CDR2 Species cross-reactivity: Bovine, mouse, primate.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
A synthetic peptide made to a C-terminal region of the human CDR2.
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
-
Approved: ELISA, IHC, WB (2 μg/mL)
Usage: Suitable for ELISA, Immunohistochemistry and Western blot: 2 μg/mL,. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate, pH 7- 8, 0.1 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- May be stored at 4°C for short-term only. For long-term storage and to avoid freeze-thaw cycles, aliquot and store at -20°C. Aliquots are stable for at least 1 year at -20°C.
-
-
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
-
Alternative Name
- Yo / CDR2
-
Background
-
Name/Gene ID: CDR2
Synonyms: CDR2, CDR62, Yo paraneoplastic antigen, PCD17, Yo -
Gene ID
- 1039
-
UniProt
- Q01850
Target
-